These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 9684803

  • 1. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
    Urano T, Nagai N, Matsuura M, Ihara H, Takada Y, Takada A.
    Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
    [Abstract] [Full Text] [Related]

  • 2. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R, Umemura K, Hashimmoto H, Urano T.
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A, Suzuki Y, Sugihara K, Kanayama N, Urano T.
    Life Sci; 2009 Jul 31; 85(5-6):220-5. PubMed ID: 19500599
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP, Schullek JR, Hanel AM, MacAllan DR.
    Anal Biochem; 1999 May 15; 270(1):24-32. PubMed ID: 10328761
    [Abstract] [Full Text] [Related]

  • 11. Novel mechanism to enhance tPA-induced fibrinolysis: effect of limited proteolysis of PAI-1 by neutrophil elastase.
    Urano T, Wu K, Ihara H, Takada Y, Takada A.
    Pol J Pharmacol; 1996 May 15; 48(2):209-13. PubMed ID: 9112653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ, Meijers JC, Levi M, van Gulik TM, Boermeester MA.
    Shock; 2007 May 15; 27(5):534-41. PubMed ID: 17438459
    [Abstract] [Full Text] [Related]

  • 15. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK, Mestries JC, Gascon MP, Ythier A.
    Thromb Haemost; 1997 May 15; 77(5):905-10. PubMed ID: 9184401
    [Abstract] [Full Text] [Related]

  • 16. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P, Morini M, Agnelli G, Ascani A, Nenci GG.
    Blood Coagul Fibrinolysis; 1993 Oct 15; 4(5):721-7. PubMed ID: 8292721
    [Abstract] [Full Text] [Related]

  • 17. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA, Cox LM, Bouma BN.
    Blood Coagul Fibrinolysis; 2006 Jun 15; 17(4):251-7. PubMed ID: 16651866
    [Abstract] [Full Text] [Related]

  • 18. Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin.
    Eriksson E, Wollter IM, Christenson B, Stigendal L, Risberg B.
    Thromb Haemost; 1988 Apr 08; 59(2):284-8. PubMed ID: 2838926
    [Abstract] [Full Text] [Related]

  • 19. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H, Suzuki Y, Sano H, Suda T, Chida K, Dan T, Miyata T, Urano T.
    Thromb Res; 2013 Jul 08; 132(1):100-5. PubMed ID: 23611258
    [Abstract] [Full Text] [Related]

  • 20. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F, Piro D, Rossiello MR, Ammollo T, Colucci M.
    Thromb Haemost; 2007 Dec 08; 98(6):1208-14. PubMed ID: 18064315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.